Key Report Takeaways By drug, semaglutide led with 51.35% of the Latin America GLP-1 agonists market share in 2025, while tirzepatide is projected to record the fastest 12.12% CAGR through 2031
Glutathione deficiency is involved in chronic diseases, including Alzheimer's disease, Parkinson's disease, liver disease, cancer, heart disease, and diabetes
For continuous and categorical variables, Students t-tests and Pearson chi-square tests were employed, respectively, to assess if there were statistically significant differences between the cohorts at the 5% level
If you want to get the right amount of selenium in the correct form then check out this supplement
Further work is needed to explore consequences of long-term use of these medications, ideal insulin deprescription protocols, and strategies to alternatively dose these medications around ongoing shortages
Potential risks to fetal development must be considered